GLP-1R Agonism's Role in Breast Cancer: A Potential Metabolic-Oncogenic Link | Retatrutide News

Research suggests a possible link between GLP-1 receptor agonism and breast cancer. This could impact the clinical applications of drugs like Retatrutide.
Clinical Trials · October 20, 2026